Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Precision Drilling
PDS
Hutchmed (China)
HCM
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
X United States Steel
- 39.490
- +1.740+4.61%
Trading Feb 27 13:48 ET
8.89BMarket Cap25.15P/E (TTM)
39.930High38.040Low3.69MVolume38.350Open37.750Pre Close144.90MTurnover1.82%Turnover Ratio25.15P/E (Static)225.22MShares47.88152wk High0.78P/B8.02BFloat Cap26.84652wk Low0.20Dividend TTM203.10MShs Float170.210Historical High0.51%Div YieldTTM5.01%Amplitude4.407Historical Low39.240Avg Price1Lot Size
United States Steel Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -56.24%919M | -46.53%208M | -67.56%265M | -33.52%474M | -115.47%-28M | -40.09%2.1B | -48.48%389M | -23.93%817M | -21.22%713M | -76.52%181M |
| Net income from continuing operations | -57.09%384M | -11.25%-89M | -60.20%119M | -61.64%183M | -14.07%171M | -64.54%895M | -145.98%-80M | -38.98%299M | -51.23%477M | -77.44%199M |
| Operating gains losses | 43.94%-74M | -20.41%39M | 42.31%-45M | 24.29%-53M | 54.55%-15M | 70.40%-132M | 153.85%49M | 43.07%-78M | 41.67%-70M | 66.33%-33M |
| Depreciation and amortization | -0.33%913M | 4.15%251M | 2.17%235M | -3.13%217M | -4.98%210M | 15.80%916M | 22.34%241M | 16.16%230M | 13.13%224M | 11.62%221M |
| Deferred tax | 16.49%113M | 84.27%-28M | -61.43%54M | -47.42%51M | -5.26%36M | -80.64%97M | -196.67%-178M | -55.41%140M | -23.02%97M | -68.60%38M |
| Other non cash items | -77.78%8M | -120.00%-3M | -72.22%5M | --0 | 500.00%6M | -25.00%36M | 266.67%15M | -21.74%18M | -88.24%2M | -94.12%1M |
| Change In working capital | -379.25%-444M | -82.49%38M | -149.52%-103M | 476.47%64M | -77.91%-443M | 309.21%159M | -59.67%217M | 11.83%208M | 96.18%-17M | 29.86%-249M |
| -Change in receivables | 68.93%174M | 5,450.00%222M | -67.37%108M | 164.81%35M | -7.30%-191M | -72.16%103M | -99.01%4M | -42.83%331M | 79.23%-54M | 49.86%-178M |
| -Change in inventory | -127.63%-71M | -181.46%-167M | -96.80%7M | --132M | 74.25%-43M | 215.77%257M | -56.84%205M | 16.49%219M | --0 | 64.24%-167M |
| -Change in payables and accrued expense | -1,240.00%-285M | 35.29%-33M | 52.83%-100M | -640.00%-74M | -126.17%-78M | 113.89%25M | 86.14%-51M | 45.22%-212M | -104.65%-10M | -17.22%298M |
| -Change in other working capital | -15.93%-262M | -72.88%16M | 9.23%-118M | -161.70%-29M | 35.15%-131M | -413.64%-226M | 136.00%59M | 32.99%-130M | 161.11%47M | -288.79%-202M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -56.24%919M | -46.53%208M | -67.56%265M | -33.52%474M | -115.47%-28M | -40.09%2.1B | -48.48%389M | -23.93%817M | -21.22%713M | -76.52%181M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 11.37%-2.28B | 22.27%-492M | 12.99%-509M | -2.94%-630M | 12.60%-645M | -52.95%-2.57B | -3.09%-633M | -26.35%-585M | -144.80%-612M | -109.66%-738M |
| Capital expenditure reported | 11.22%-2.29B | 20.72%-505M | 12.80%-511M | -2.94%-631M | 13.51%-640M | -45.62%-2.58B | -0.95%-637M | -22.59%-586M | -97.11%-613M | -112.03%-740M |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | 37.50%11M | 225.00%13M | 100.00%2M | 0.00%1M | -350.00%-5M | -89.74%8M | -20.00%4M | -93.33%1M | -98.36%1M | 166.67%2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 11.37%-2.28B | 22.27%-492M | 12.99%-509M | -2.94%-630M | 12.60%-645M | -52.95%-2.57B | -3.09%-633M | -26.35%-585M | -144.80%-612M | -109.66%-738M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -103.06%-199M | -111.11%-95M | 64.56%-28M | -120.98%-30M | 60.68%-46M | 88.71%-98M | 61.21%-45M | 61.27%-79M | 129.98%143M | -64.79%-117M |
| Net issuance payments of debt | -184.21%-128M | -310.00%-82M | 71.74%-13M | -108.33%-19M | -40.00%-14M | 489.74%152M | -144.44%-20M | -206.67%-46M | 440.30%228M | -400.00%-10M |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | 79.39%-175M | --0 | 85.88%-25M | 81.20%-75M | 39.02%-75M |
| Net other financing activities | 5.33%-71M | 48.00%-13M | -87.50%-15M | -10.00%-11M | 0.00%-32M | -475.00%-75M | -127.27%-25M | 33.33%-8M | 9.09%-10M | -159.26%-32M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -103.06%-199M | -111.11%-95M | 64.56%-28M | -120.98%-30M | 60.68%-46M | 88.71%-98M | 61.21%-45M | 61.27%-79M | 129.98%143M | -64.79%-117M |
| Net cash flow | ||||||||||
| Beginning cash position | -15.57%2.99B | -44.31%1.82B | -33.49%2.07B | -21.27%2.26B | -15.57%2.99B | 36.12%3.54B | -6.54%3.26B | 0.58%3.12B | -2.31%2.87B | 36.12%3.54B |
| Current changes in cash | -174.91%-1.56B | -31.14%-379M | -277.78%-272M | -176.23%-186M | -6.68%-719M | -159.08%-566M | -1,256.00%-289M | -62.41%153M | 37.08%244M | -293.68%-674M |
| Effect of exchange rate changes | -226.67%-19M | -227.78%-23M | 227.27%14M | ---3M | -187.50%-7M | 178.95%15M | -33.33%18M | 42.11%-11M | --0 | 214.29%8M |
| End cash Position | -52.71%1.41B | -52.71%1.41B | -44.31%1.82B | -33.49%2.07B | -21.27%2.26B | -15.57%2.99B | -15.57%2.99B | -6.54%3.26B | 0.58%3.12B | -2.31%2.87B |
| Free cash flow | -187.39%-1.37B | -19.76%-297M | -206.49%-246M | -257.00%-157M | -19.50%-668M | -127.42%-476M | -300.00%-248M | -61.24%231M | -83.16%100M | -232.46%-559M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
